The U.S. Air Force Research Laboratory selected Science Applications
International Corp. (NYSE: SAIC) to research laser bioeffects, advance
vision science, conduct modeling and simulation, and perform safety
engineering, awarding the company a $58 million Optical Radiation
Bioeffects and Safety contract. The research program will enhance airman
combat survivability by enabling U.S. forces to counter optical hazards
and threats.
“We need to keep airmen safe and able to perform their missions
effectively on a directed energy battlefield,” said Michael LaRouche,
executive vice president and general manager of SAIC’s National Security
Customer Group. “Having delivered in-house research for the 711 Human
Performance Wing – Optical Radiation Bioeffects Branch for the past 26
years, we’re well positioned to deliver next generation solutions in
optical warfare.”
Under the 75-month, cost-plus, fixed-fee contract, SAIC’s team will
cover wide-ranging research to define thresholds for biological injury
and correlate optical exposure with performance. SAIC will also leverage
machine learning capabilities from its Solutions and Technology Group as
they seek to enhance laser injury assessments.
About SAIC
SAIC is a premier technology integrator solving our nation’s most
complex modernization and readiness challenges across the defense,
space, federal civilian, and intelligence markets. Our robust portfolio
of offerings includes high-end solutions in systems engineering and
integration; enterprise IT, including cloud services; cyber; software;
advanced analytics and simulation; and training. With an intimate
understanding of our customers’ challenges and deep expertise in
existing and emerging technologies, we integrate the best components
from our own portfolio and our partner ecosystem to rapidly deliver
innovative, effective, and efficient solutions.
We are a team of 23,000 strong driven by mission, united purpose, and
inspired by opportunity. Headquartered in Reston, Virginia, SAIC has
annual revenues of approximately $6.5 billion. For more information,
visit saic.com. For
ongoing news, please visit our newsroom.
Forward-Looking Statements
Certain statements in this release contain or are based on
“forward-looking” information within the meaning of the Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify forward-looking statements by words such as “expects,”
“intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,”
and similar words or phrases. Forward-looking statements in this release
may include, among others, estimates of future revenues, operating
income, earnings, earnings per share, charges, total contract value,
backlog, outstanding shares and cash flows, as well as statements about
future dividends, share repurchases and other capital deployment plans.
Such statements are not guarantees of future performance and involve
risk, uncertainties and assumptions, and actual results may differ
materially from the guidance and other forward-looking statements made
in this release as a result of various factors. Risks, uncertainties and
assumptions that could cause or contribute to these material differences
include those discussed in the “Risk Factors,” “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” and
“Legal Proceedings” sections of our Annual Report on Form 10-K, as
updated in any subsequent Quarterly Reports on Form 10-Q and other
filings with the SEC, which may be viewed or obtained through the
Investor Relations section of our website at saic.com
or on the SEC’s website at sec.gov.
Due to such risks, uncertainties and assumptions you are cautioned not
to place undue reliance on such forward-looking statements, which speak
only as of the date hereof. SAIC expressly disclaims any duty to update
any forward-looking statement provided in this release to reflect
subsequent events, actual results or changes in SAIC’s expectations.
SAIC also disclaims any duty to comment upon or correct information that
may be contained in reports published by investment analysts or others.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190508005056/en/